Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Ischemic Heart Disease (IHD) clinical trials

2 of 2 indexed Ischemic Heart Disease (IHD) trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Ischemic Heart Disease (IHD): 2 US clinical trials tracked, 2 recruiting.

Ischemic Heart Disease (IHD) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Brigham and Women's Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition ischemic-heart-disease-ihd

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Ischemic Heart Disease (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Ischemic Heart Disease (IHD)

Ischemic Heart Disease (IHD) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Ischemic Heart Disease (IHD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Ischemic Heart Disease (IHD) is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Ischemic Heart Disease (IHD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vasodilator Drug
1 trials
Gadavist Drug
1 trials
Qualitative Myocardial Blood Flow Evaluation Diagnostic test
1 trials
Quantitative Myocardial Blood Flow Evaluation Diagnostic test
1 trials
Blood draw for the laboratory assessment Diagnostic test
1 trials

US sites by state

Facility locations filed on Ischemic Heart Disease (IHD) trials. A trial with sites in several states counts in each.

Texas 2 trials
Virginia 1 trials
Tennessee 1 trials
North Carolina 1 trials
Massachusetts 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Ischemic Heart Disease (IHD) page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ischemic Heart Disease (IHD) condition card totals 2 registered trials; most-linked intervention Vasodilator; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.